System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Angsuman Das Chaudhuri, PhD is an expert in Biochemistry at Vidyasagar University (India). Angsuman Das Chaudhuri has authored 11 publications, the most recent in 2026. SLR score: 37 (community average: 125). How the SLR is computed.

LeadR Profile

Angsuman Das Chaudhuri, PhD Vidyasagar University India
37 ScienceLeadR Reputation 37

Unlock

Register Login
Network Map

Biochemistry

Subspecialties: Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2021 - 2026
Source: PubMed

Vidyasagar University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 11

Citations

Citations: 22 1st author: 3 Last author: 0 Unique author: 0

Main journals

International Journal of Innovative Science and Research Technology (IJISRT) 3
ACS Appl Bio Mater 2
ACS Omega 1
Applied Research 1
Cancer Res 1

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Rationally engineered PEGylated l-citrulline functionalized baicalein encapsulated HSA nanopolymer guided by molecular docking for tumor microenvironment responsive and redox modulated colon cancer therapy.
PMID 41488536 — cells, serum albumin, serum, neoplasms, colon, citrulline, therapeutics, serum albumin, human, tumor microenvironment, colonic neoplasms		RSC Adv20260
TPGS-Transferrin-Conjugated Carvacrol-Loaded pH-Responsive Polydopamine Nanoconjugate: A Structure-Property Interplay Emphasizing Estrogen Receptor Positive Breast Cancer Cell and Involving In Vitro and In Vivo Toxicity Assessment Studies in Experimental Models.
PMID 41427647 — cells, estrogens, nanoconjugates, breast neoplasms, transferrin, receptors, estrogen, antineoplastic agents, neoplasms, biocompatible materials, breast, therapeutics		ACS Appl Bio Mater20250
Folate receptor-targeted and pH-tunable dextran modified geraniol-protein nano-scaffolds stir up oxidative assault and apoptotic killing of HCT-116 colorectal cancer cells.
PMID 40049483 — cells, stress, physiological, neoplasms, oxidative stress, therapeutics, colorectal neoplasms, apoptosis		Int J Biol Macromol20250
Nanoconjugate Carrying pH-Responsive Transferrin Receptor-Targeted Hesperetin Triggers Triple-Negative Breast Cancer Cell Death through Oxidative Attack and Assemblage of Pro-Apoptotic Proteins.
PMID 39504304 — cells, triple negative breast neoplasms, nanoconjugates, breast neoplasms, nanoparticles, transferrin, neoplasms, biocompatible materials, breast, receptors, transferrin, therapeutics, apoptosis, cell death, ascites, cell cycle		ACS Appl Bio Mater20244
Anacardium Occidentale-Derived Nanoparticles as a Biocompatible Targeted Therapy for Breast Cancer Cells
OpenAlex W4404049451 — cells, breast neoplasms, nanoparticles, neoplasms, breast, therapeutics		International Journal of Innovative Science and Research Technology (IJISRT)20240

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS